Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 3-(2,4-dimethyl-1H-pyrrol-3-yl)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

775322-46-8

Post Buying Request

775322-46-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

775322-46-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 775322-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,5,3,2 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 775322-46:
(8*7)+(7*7)+(6*5)+(5*3)+(4*2)+(3*2)+(2*4)+(1*6)=178
178 % 10 = 8
So 775322-46-8 is a valid CAS Registry Number.

775322-46-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2,4-dimethyl-1H-pyrrol-3-yl)-benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:775322-46-8 SDS

775322-46-8Relevant academic research and scientific papers

5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors

-

Page/Page column 25, (2010/02/08)

The present invention relates to 5-sulfonamido substituted indolinones that modulate the activity of protein kinases (“PKs”). The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)

-

Page 21, (2010/02/10)

The present invention relates generally to the field of radiosensitizing agents which are capable of enhancing radiotherapy by inhibiting DNA-PK (DNA-protein kinase). In particular, it relates to sulfonamide substituted indolinones which inhibit DNA-PK.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 775322-46-8